anacardic acid has been researched along with guttiferone e in 1 studies
Studies (anacardic acid) | Trials (anacardic acid) | Recent Studies (post-2010) (anacardic acid) | Studies (guttiferone e) | Trials (guttiferone e) | Recent Studies (post-2010) (guttiferone e) |
---|---|---|---|---|---|
177 | 1 | 120 | 20 | 0 | 16 |
Protein | Taxonomy | anacardic acid (IC50) | guttiferone e (IC50) |
---|---|---|---|
Prostaglandin E synthase | Homo sapiens (human) | 0.3 | |
Cytochrome P450 2B6 | Homo sapiens (human) | 0.5 | |
Cytochrome P450 2C19 | Homo sapiens (human) | 0.5 | |
Histone acetyltransferase p300 | Homo sapiens (human) | 5.375 | |
Histone acetyltransferase KAT2B | Homo sapiens (human) | 5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, K; Chen, Y; Chen, Z; Ding, H; Han, J; Jiang, H; Liu, YC; Lu, T; Lu, W; Luo, C; Wang, C; Wang, J; Xiao, S; Xiong, H; Xu, P; Yang, Y; Yue, L; Zhang, C; Zhang, H; Zhang, Y; Zhou, B | 1 |
1 other study(ies) available for anacardic acid and guttiferone e
Article | Year |
---|---|
Discovery and biological evaluation of thiobarbituric derivatives as potent p300/CBP inhibitors.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Drug Discovery; Enzyme Inhibitors; Female; Humans; Leukemia; Mice, Nude; Molecular Docking Simulation; p300-CBP Transcription Factors; Thiobarbiturates; Transcriptome | 2018 |